http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2149610-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fb757fd92b11f285aaad8bf6ab2774a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07ae8f62e2b7fe88d2a7010ff1861b1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb5823374440c20fca9dd73c244a8d34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
filingDate 1997-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f69940c4ce68820d692bcf5f9c4ba9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e8be3ac2224fc28d75ec15576ee8885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b4103e5923699d94264459b972e247e
publicationDate 2000-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2149610-C1
titleOfInvention Method for viral keratoconjunctivitis aggravated with immunoglobulin a deficiency
abstract FIELD: medicine. SUBSTANCE: method involves applying interferonogen preparation of Poludan administered as injections and instillations combined with Chigain preparation therapy administered as instillations into conjunctival cavity. EFFECT: accelerated treatment of viral conjunctivitis.
priorityDate 1997-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390989
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11355923
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2725057

Total number of triples: 22.